Skip to content
DraconiticResearch
Search Sources API
220,595 studies31 sourcesUpdated 27 min ago
Peer-reviewedCC BY 4.0Cell Death Discovery

LINC02709 facilitates hepatocellular carcinoma metastasis by increasing stem cell-like properties and suppressing Kupffer cell phagocytosis

4 affiliations
  1. 1Department of Pathology, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China
  2. 2Guangxi Clinical Medical Research Center of Hepatobiliary Disease, Baise, China
  3. 3Department of Hepatobiliary Surgery, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China
  4. 4Graduate College of Youjiang Medical University for Nationalities, Baise, China

Abstract

Hepatocellular carcinoma (HCC) exhibits a high propensity for metastasis and recurrence, leading to poor prognosis. Intrahepatic metastasis is more common than extrahepatic spread. Metastases arise through diverse mechanisms, including the involvement of cancer stem cells (CSCs) and the immune-modulatory role of the liver tissue microenvironment. As hepatic resident macrophages, Kupffer cells play a critical role in immune surveillance by phagocytosing disseminated HCC cells. However, the molecules regulating HCC cell stemness properties, Kupffer cell phagocytosis, and further HCC intrahepatic metastasis remain poorly understood. In the present study, we found that the long noncoding RNA LINC02709 was upregulated in HCC and correlated with stemness properties, intrahepatic metastasis, and poor prognosis. LINC02709 not only enhanced stemness properties of HCC cells, but also suppressed the phagocytosis of HCC cells by Kupffer cells, leading to increased liver metastasis. LINC02709 upregulated CD24 and CD47, which mediated the effects of LINC02709 on HCC cell stemness properties and Kupffer cell phagocytosis. LINC02709 was identified as an m6A-modified transcript. m6A-modified LINC02709 bound and recruited the m6A reader FXR1 and the DNA demethylase TET1 to the CD24 and CD47 promoters, inducing DNA demethylation and transcriptional activation of CD24 and CD47. The effects of LINC02709 on CD24/CD47, stemness properties, phagocytosis, and liver metastasis were all dependent on m6A modification. Our findings demonstrate that m6A-modified LINC02709 is a novel and promising biomarker for HCC recurrence and survival, enhancing HCC cell stemness properties, suppressing Kupffer cell phagocytosis, and driving HCC intrahepatic metastasis by epigenetically activating CD24 and CD47. Targeting m6A-modified LINC02709 represents a promising therapeutic strategy for HCC.

Related

  1. TARBP2 facilitates renal cell carcinoma immune escape by suppressing 53BP1 phase separation to upregulate B7-H3.
    Minyu Chen, Mingjie Lin, Jiangquan Zhu +18
    The Journal of clinical investigationPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  2. CDCA5 promotes hepatocellular carcinoma progression by suppressing ferroptosis through PP2Ac/p53/STEAP3 signaling
    Di Wu, Haonan Zhou, Shiqi Liu +5
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref
  3. Tonsillar metastasis from hepatocellular carcinoma: a case report and literature review
    Jianhao Yang, Yujuan Dai, Lusheng Wen +2
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  4. Silent Invasion: Isolated Right Ventricular Metastasis from Hepatocellular Carcinoma Diagnosed by Transvenous Biopsy.
    Mounika Reddy Vadiyala, Sehajpreet Singh, Azka Naeem +8
    Case reports in cardiologyPeer-reviewedCC BYFull textCardiovascular medicineEurope PMCPMC
  5. Solitary Skull Metastasis as Initial Presentation of Hepatocellular Carcinoma: A Rare Case Report and Management Review
    Ashish Chugh, Dipti Patil, Prashant Punia +1
    Annals of African MedicinePeer-reviewedCC BY-NC-SA 4.0Full textOncologyPMC
BibTeX
@article{wei2026linc02709,
  title = {{LINC02709 facilitates hepatocellular carcinoma metastasis by increasing stem cell-like properties and suppressing Kupffer cell phagocytosis}},
  author = {Huamei Wei and Wenchuan Li and Xianjian Wu and Rongzhou Lu and Gaoxiong Tan and Yunyu Wei and Quan Fang and Youguan Huang and Zhongheng Wei and Jian Pu},
  journal = {Cell Death Discovery},
  year = {2026},
  month = aug,
  doi = {10.1038/s41420-026-03276-8},
  url = {https://doi.org/10.1038/s41420-026-03276-8},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - LINC02709 facilitates hepatocellular carcinoma metastasis by increasing stem cell-like properties and suppressing Kupffer cell phagocytosis
AU  - Huamei Wei
AU  - Wenchuan Li
AU  - Xianjian Wu
AU  - Rongzhou Lu
AU  - Gaoxiong Tan
AU  - Yunyu Wei
AU  - Quan Fang
AU  - Youguan Huang
AU  - Zhongheng Wei
AU  - Jian Pu
PY  - 2026
DA  - 2026/08/12
JO  - Cell Death Discovery
DO  - 10.1038/s41420-026-03276-8
UR  - https://doi.org/10.1038/s41420-026-03276-8
AB  - Hepatocellular carcinoma (HCC) exhibits a high propensity for metastasis and recurrence, leading to poor prognosis. Intrahepatic metastasis is more common than extrahepatic spread. Metastases arise through diverse mechanisms, including the involvement of cancer stem cells (CSCs) and the immune-modulatory role of the liver tissue microenvironment. As hepatic resident macrophages, Kupffer cells play a critical role in immune surveillance by phagocytosing disseminated HCC cells. However, the molecules regulating HCC cell stemness properties, Kupffer cell phagocytosis, and further HCC intrahepatic metastasis remain poorly understood. In the present study, we found that the long noncoding RNA LINC02709 was upregulated in HCC and correlated with stemness properties, intrahepatic metastasis, and poor prognosis. LINC02709 not only enhanced stemness properties of HCC cells, but also suppressed the phagocytosis of HCC cells by Kupffer cells, leading to increased liver metastasis. LINC02709 upregulated CD24 and CD47, which mediated the effects of LINC02709 on HCC cell stemness properties and Kupffer cell phagocytosis. LINC02709 was identified as an m6A-modified transcript. m6A-modified LINC02709 bound and recruited the m6A reader FXR1 and the DNA demethylase TET1 to the CD24 and CD47 promoters, inducing DNA demethylation and transcriptional activation of CD24 and CD47. The effects of LINC02709 on CD24/CD47, stemness properties, phagocytosis, and liver metastasis were all dependent on m6A modification. Our findings demonstrate that m6A-modified LINC02709 is a novel and promising biomarker for HCC recurrence and survival, enhancing HCC cell stemness properties, suppressing Kupffer cell phagocytosis, and driving HCC intrahepatic metastasis by epigenetically activating CD24 and CD47. Targeting m6A-modified LINC02709 represents a promising therapeutic strategy for HCC.
SN  - 2058-7716
ER  -